Diabetologia

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

P. C. Butler, A. V. Matveyenko, S. Dry, A. Bhushan, R. Elashoff

Leptin therapy in lipodystrophy

D. B. Savage, S. O’Rahilly

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation

H. Kolb, T. Mandrup-Poulsen

Pancreatic duct replication is increased with obesity and type 2 diabetes in humans

A. E. Butler, R. Galasso, A. Matveyenko, R. A. Rizza, S. Dry, P. C. Butler

Efficacy of leptin therapy in the different forms of human lipodystrophy

A. Y. Chong, B. C. Lupsa, E. K. Cochran, P. Gorden

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients

E. Vandemeulebroucke, B. Keymeulen, K. Decochez, I. Weets, C. De Block, F. Féry, U. Van de Velde, I. Vermeulen, P. De Pauw, C. Mathieu, D. G. Pipeleers, F. K. Gorus

Telomere length predicts all-cause mortality in patients with type 1 diabetes

A. S. Astrup, L. Tarnow, A. Jorsal, M. Lajer, R. Nzietchueng, A. Benetos, P. Rossing, H.-H. Parving

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study

E. Ritz, G. C. Viberti, L. M. Ruilope, A. J. Rabelink, J. L. Izzo Jr, S. Katayama, S. Ito, A. Mimran, J. Menne, L. C. Rump, A. Januszewicz, H. Haller

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus

E. van den Berg, Y. D. Reijmer, J. de Bresser, R. P. C. Kessels, L. J. Kappelle, G. J. Biessels

Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1

B. E. McGuire, T. G. Morrison, N. Hermanns, S. Skovlund, E. Eldrup, J. Gagliardino, A. Kokoszka, D. Matthews, M. Pibernik-Okanović, J. Rodríguez-Saldaña, M. de Wit, F. J. Snoek

Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study

S. Engberg, C. Glümer, D. R. Witte, T. Jørgensen, K. Borch-Johnsen

HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study

E. L. M. Barr, A. J. Cameron, B. Balkau, P. Z. Zimmet, T. A. Welborn, A. M. Tonkin, J. E. Shaw

Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort

D. A. Lawlor, A. Fraser, R. S. Lindsay, A. Ness, D. Dabelea, P. Catalano, G. Davey Smith, N. Sattar, S. M. Nelson

The interferon-induced helicase IFIH1 Ala946Thr polymorphism is associated with type 1 diabetes in both the high-incidence Finnish and the medium-incidence Hungarian populations

A. Jermendy, I. Szatmári, A. P. Laine, K. Lukács, K. H. Horváth, A. Körner, L. Madácsy, R. Veijola, O. Simell, M. Knip, J. Ilonen, R. Hermann

Genetic association analysis of LARS2 with type 2 diabetes

E. Reiling, B. Jafar-Mohammadi, E. van ’t Riet, M. N. Weedon, J. V. van Vliet-Ostaptchouk, T. Hansen, R. Saxena, T. W. van Haeften, P. A. Arp, S. Das, G. Nijpels, M. J. Groenewoud, E. C. van Hove, A. G. Uitterlinden, J. W. A. Smit, A. D. Morris, A. S. F. Doney, C. N. A. Palmer, C. Guiducci, A. T. Hattersley, T. M. Frayling, O. Pedersen, P. E. Slagboom, D. M. Altshuler, L. Groop, J. A. Romijn, J. A. Maassen, M. H. Hofker, J. M. Dekker, M. I. McCarthy, L. M. ’t Hart

Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys

Y. Saisho, A. E. Butler, E. Manesso, R. Galasso, L. Zhang, T. Gurlo, G. M. Toffolo, C. Cobelli, K. Kavanagh, J. D. Wagner, P. C. Butler

OVO homologue-like 1 (Ovol1) transcription factor: a novel target of neurogenin-3 in rodent pancreas

A. Vetere, W.-C. Li, F. Paroni, K. Juhl, L. Guo, W. Nishimura, X. Dai, S. Bonner-Weir, A. Sharma

Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice

J. Krützfeldt, M. Stoffel

Single pancreatic beta cells co-express multiple islet hormone genes in mice

H. Katsuta, T. Akashi, R. Katsuta, M. Nagaya, D. Kim, Y. Arinobu, M. Hara, S. Bonner-Weir, A. J. Sharma, K. Akashi, G. C. Weir

Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise

E. Y. H. Khoo, J. Wallis, K. Tsintzas, I. A. Macdonald, P. Mansell

An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics

A. Tura, S. Sbrignadello, E. Succurro, L. Groop, G. Sesti, G. Pacini

Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas

J. S. Nachnani, D. G. Bulchandani, A. Nookala, B. Herndon, A. Molteni, P. Pandya, R. Taylor, T. Quinn, L. Weide, L. M. Alba

Diabetes regulates mitochondrial biogenesis and fission in mouse neurons

J. L. Edwards, A. Quattrini, S. I. Lentz, C. Figueroa-Romero, F. Cerri, C. Backus, Y. Hong, E. L. Feldman

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis

Y. Pham, Y. Tu, T. Wu, T. J. Allen, A. C. Calkin, A. M. Watson, J. Li, K. A. Jandeleit-Dahm, B-H. Toh, Z. Cao, M. E. Cooper, Z. Chai

Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes

Y. F. Dong, L. Liu, K. Kataoka, T. Nakamura, M. Fukuda, Y. Tokutomi, H. Nako, H. Ogawa, S. Kim-Mitsuyama

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

A. M. D. Watson, J. Li, C. Schumacher, M. de Gasparo, B. Feng, M. C. Thomas, T. J. Allen, M. E. Cooper, K. A. M. Jandeleit-Dahm

Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues

D. Simon

Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine

J. M. Nagel, U. Mansmann, K. Wegscheider, J. Röhmel

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]

U. Grouven, L. G. Hemkens, R. Bender, P. T. Sawicki

Dualities of interest are not restricted to financial ties to the pharmaceutical industry

M. Nauck

Duration of diabetes, glucose control and cardiovascular risk

N. V. Emanuele

Using individual patient data in meta-analyses of glucose-lowering studies

J. S. Yudkin, B. Richter

Intensive glucose control and macrovascular outcomes in type 2 diabetes. Reply to Emanuele NV [letter] and Yudkin JS, Richter B [letter]

Erratum to: Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro

S. K. Pinnamaneni, R. J. Southgate, M. A. Febbraio, M. J. Watt

List of referees